Trials / Completed
CompletedNCT03476746
Dermatopharmacokinetic Trial of LEO 90100 Foam
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This is a phase 1, single centre trial in Japanese healthy male subjects comparing the amount of active ingredients of LEO 90100 foam and Dovobet® ointment in the stratum corneum.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 90100 foam | A foam formulation of the active comparator Dovobet® ointment |
| DRUG | Dovobet® ointment | Ointment formulation containing same active ingredients as LEO 90100 foam |
Timeline
- Start date
- 2018-03-20
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2018-03-26
- Last updated
- 2025-02-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03476746. Inclusion in this directory is not an endorsement.